Sébastien Couraud Acute Respiratory Disease and Thoracic Oncology Department, Lyon Sud Hospital Hospices Civils de Lyon Cancer Institute Biography Publications Institution JoVE Articles Sébastien Couraud has not added a biography. If you are Sébastien Couraud and would like to personalize this page please email our Author Liaison for assistance. Publications Profiling of Circulating Tumor DNA in Plasma of Non-small Cell Lung Cancer Patients, Monitoring of Epidermal Growth Factor Receptor P.T790M Mutated Allelic Fraction Using Beads, Emulsion, Amplification, and Magnetics Companion Assay and Evaluation in Future Application in Mimicking Circulating Tumor Cells Cancer Medicine. Jul, 2019 | Pubmed ID: 31112372 Cross-platform Comparison for the Detection of RAS Mutations in CfDNA (ddPCR Biorad Detection Assay, BEAMing Assay, and NGS Strategy) Oncotarget. Apr, 2018 | Pubmed ID: 29765524 Concerns About Lung Cancer Among Prisoners Lung. 02, 2018 | Pubmed ID: 29299681 Association Between Lung Cancer Somatic Mutations and Occupational Exposure in Never-smokers The European Respiratory Journal. 10, 2017 | Pubmed ID: 29074543 Implementing Flexible Bronchoscopy in Least Developed Countries According to International Guidelines is Feasible and Sustainable: Example from Phnom-Penh, Cambodia BMC Pulmonary Medicine. 01, 2017 | Pubmed ID: 28073342 [Economic Impact of Lung Cancer Screening in France: A Modeling Study] Revue Des Maladies Respiratoires. Sep, 2017 | Pubmed ID: 26585377 Somatic Alterations in Lung Cancer: Do Environmental Factors Matter? Lung Cancer (Amsterdam, Netherlands). 10, 2016 | Pubmed ID: 27597280 Inequalities in Lung Cancer: a World of EGFR The European Respiratory Journal. 05, 2016 | Pubmed ID: 27030679 [Script Concordance Test for Knowledge Assessment of Lung Cancer Screening] Revue Des Maladies Respiratoires. May, 2016 | Pubmed ID: 26603957 [Patient's Beliefs About Oral Targeted Therapies and Impact on Drug Adherence in Lung Cancer: A Pilot Prospective Study] Revue De Pneumologie Clinique. Feb, 2016 | Pubmed ID: 26210879 [Lung Function in Patients with Diabetes Mellitus] Revue De Pneumologie Clinique. Feb, 2016 | Pubmed ID: 26195118 [Free Circulating DNA As a Tool for Lung Cancer Patients Management] Revue De Pneumologie Clinique. Feb, 2016 | Pubmed ID: 26190335 Circulating Free DNA Concentration is an Independent Prognostic Biomarker in Lung Cancer The European Respiratory Journal. Dec, 2015 | Pubmed ID: 26493785 BioCAST/IFCT-1002: Epidemiological and Molecular Features of Lung Cancer in Never-smokers The European Respiratory Journal. May, 2015 | Pubmed ID: 25657019 Negative Predictive Value of Transthoracic Core-Needle Biopsy: A Multicenter Study Chest. Aug, 2015 | Pubmed ID: 25569025 [Paclitaxel-bevacizumab is a Possible Alternative As Salvage Chemotherapy in Advanced Non-small Cell Bronchial Carcinoma] Revue Des Maladies Respiratoires. Sep, 2014 | Pubmed ID: 25239581 [Pulmonary Diffusion Test to NO and CO Time Course During Thoracic Radiotherapy for Lung Cancer: the CONORT Prospective Study Protocol] Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique. Oct, 2014 | Pubmed ID: 25205426 Noninvasive Diagnosis of Actionable Mutations by Deep Sequencing of Circulating Free DNA in Lung Cancer from Never-smokers: a Proof-of-concept Study from BioCAST/IFCT-1002 Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Sep, 2014 | Pubmed ID: 25013125 [Lung Cancer in Never Smokers: a French National Cohort (BioCAST/IFCT-1002)] Revue Des Maladies Respiratoires. Sep, 2013 | Pubmed ID: 24034464 Physicians' Knowledge and Practice of Lung Cancer Screening: a Cross-sectional Survey Comparing General Practitioners, Thoracic Oncologists, and Pulmonologists in France Clinical Lung Cancer. Sep, 2013 | Pubmed ID: 23830707 Lung Cancer in Never Smokers--a Review European Journal of Cancer (Oxford, England : 1990). Jun, 2012 | Pubmed ID: 22464348 Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence Jessica Garcia1,2,3, David Barthelemy1,2,3, Florence Geiguer1,2, Julie Ballandier1,2,3, Kathryn W. Li4, Jean-Phillippe Aurel4, Frédérique Le Breton5, Claire Rodriguez-Lafrasse1, Brigitte Manship3, Sébastien Couraud6,7, Léa Payen1,2,3 1Laboratoire de Biochimie et Biologie Moléculaire, Groupe Hospitalier Sud, Hospices Civils de Lyon, 2Circulating Cancer (CIRCAN) Program, Hospices Civils de Lyon Cancer Institute, 3University of Lyon, Claude Bernard University, Cancer Research Center of Lyon, 4Biolidics Limited, 5Institut de Pathologie Multisites des HCL-Site Sud, Hospices Civils de Lyon, 6Acute Respiratory Disease and Thoracic Oncology Department, Lyon Sud Hospital, Hospices Civils de Lyon Cancer Institute, 7EMR-3738 Therapeutic Targeting in Oncology, Lyon Sud Medical Faculty, Lyon 1 University JoVE 59873 Recherche en cancérologie
Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence Jessica Garcia1,2,3, David Barthelemy1,2,3, Florence Geiguer1,2, Julie Ballandier1,2,3, Kathryn W. Li4, Jean-Phillippe Aurel4, Frédérique Le Breton5, Claire Rodriguez-Lafrasse1, Brigitte Manship3, Sébastien Couraud6,7, Léa Payen1,2,3 1Laboratoire de Biochimie et Biologie Moléculaire, Groupe Hospitalier Sud, Hospices Civils de Lyon, 2Circulating Cancer (CIRCAN) Program, Hospices Civils de Lyon Cancer Institute, 3University of Lyon, Claude Bernard University, Cancer Research Center of Lyon, 4Biolidics Limited, 5Institut de Pathologie Multisites des HCL-Site Sud, Hospices Civils de Lyon, 6Acute Respiratory Disease and Thoracic Oncology Department, Lyon Sud Hospital, Hospices Civils de Lyon Cancer Institute, 7EMR-3738 Therapeutic Targeting in Oncology, Lyon Sud Medical Faculty, Lyon 1 University JoVE 59873 Recherche en cancérologie